News

Provent - Are you concerned about exposure to COVID-19?

Consider participating in the PROVENT study for COVID-19 prevention


The PROVENT study is investigating a combination of two experimental monoclonal antibodies for the prevention of COVID-19. The study drug has not yet been approved by regulatory authorities and can only be given to people as part of a clinical research study. You may be eligible to participate if:

  • You are 18 years or older;
  • You have not had a previously confirmed diagnosis of COVID-19;
  • you are at higher risk of getting COVID-19 or are less likely than most adults to benefit from a vaccine (for example, because of older age, obesity or immunosuppression due to a health condition or medication).

Would you like to know more about the study?

If you would like to know more about the PROVENT study, please contact:




Subscribe to our quarterly newsletter and stay informed about new studies and developments.